SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Susceptibility of human Plasmodium knowlesi infections to anti-malarials.

Fatih, FA; Staines, HM; Siner, A; Ahmed, MA; Woon, LC; Pasini, EM; Kocken, CH; Singh, B; Cox-Singh, J; Krishna, S (2013) Susceptibility of human Plasmodium knowlesi infections to anti-malarials. MALARIA JOURNAL, 12 (425). ISSN 1475-2875 https://doi.org/10.1186/1475-2875-12-425
SGUL Authors: Krishna, Sanjeev Staines, Henry Michael

[img]
Preview
["document_typename_application/pdf; charset=binary" not defined] Published Version
Download (439kB) | Preview

Abstract

BACKGROUND: Evidence suggests that Plasmodium knowlesi malaria in Sarawak, Malaysian Borneo remains zoonotic, meaning anti-malarial drug resistance is unlikely to have developed in the absence of drug selection pressure. Therefore, adequate response to available anti-malarial treatments is assumed. METHODS: Here the ex vivo sensitivity of human P. knowlesi isolates in Malaysian Borneo were studied, using a WHO schizont maturation assay modified to accommodate the quotidian life cycle of this parasite. The in vitro sensitivities of P. knowlesi H strain adapted from a primate infection to in vitro culture (by measuring the production of Plasmodium lactate dehydrogenase) were also examined together with some assays using Plasmodium falciparum and Plasmodium vivax. RESULTS: Plasmodium knowlesi is uniformly highly sensitive to artemisinins, variably and moderately sensitive to chloroquine, and less sensitive to mefloquine. CONCLUSIONS: Taken together with reports of clinical failures when P. knowlesi is treated with mefloquine, the data suggest that caution is required if using mefloquine in prevention or treatment of P. knowlesi infections, until further studies are undertaken.

Item Type: Article
Additional Information: © 2013 Fatih et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Science & Technology, Life Sciences & Biomedicine, Infectious Diseases, Parasitology, Tropical Medicine, PARASITOLOGY, TROPICAL MEDICINE, Artemisinin, Artemether, Artesunate, Dihydroartemisinin, DHA, Chloroquine, Mefloquine, Malaria, IN-VITRO, MEFLOQUINE RESISTANCE, VIVAX MALARIA, PFMDR1 GENE, FALCIPARUM, MALAYSIA, SENSITIVITY, SABAH, ERYTHROCYTES, ADAPTATION
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: MALARIA JOURNAL
ISSN: 1475-2875
Related URLs:
Dates:
DateEvent
19 November 2013Published
Web of Science ID: WOS:000329105900001
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
URI: https://openaccess.sgul.ac.uk/id/eprint/104415
Publisher's version: https://doi.org/10.1186/1475-2875-12-425

Actions (login required)

Edit Item Edit Item